CLINICAL TRIALS PROFILE FOR DESMOPRESSIN ACETATE
✉ Email this page to a colleague
All Clinical Trials for Desmopressin Acetate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00111215 ↗ | Treatment and Management of Women With Bleeding Disorders | Completed | Centers for Disease Control and Prevention | N/A | 2001-01-01 | The purpose of the study is to determine whether oral contraceptives, desmopressin acetate, and/or tranexamic acid are effective in the treatment of women with menorrhagia who are diagnosed with a bleeding disorder. |
| NCT00477490 ↗ | Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia | Completed | Ferring Pharmaceuticals | Phase 3 | 2007-05-01 | The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia. |
| NCT00835211 ↗ | Desmopressin Acetate 0.2 mg Tablets, Fasting | Completed | Teva Pharmaceuticals USA | Phase 1 | 2003-07-01 | The objective of this study was to compare the single-dose relative bioavailability of TEVA and Aventis Pharmaceuticals (DDAVP®) 0.2 mg desmopressin acetate tablets following a 0.8 mg dose under fasting conditions. |
| NCT01982760 ↗ | DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty | Unknown status | University Hospitals Cleveland Medical Center | Phase 2 | 2013-12-01 | This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a drug used in patients with bleeding disorders. It works by activating molecules in the blood stream called platelets that promote clotting. In the study, participants who are have cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive medication. Photographs taken before and shortly after surgery will be evaluated for the amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not eligible to participate. |
| NCT02538302 ↗ | Minirin Versus Oxybutynin for Nocturnal Enuresis in Children | Completed | Hormozgan University of Medical Sciences | Phase 3 | 2013-07-01 | Nocturnal enuresis is among the most common disorders in children. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014. |
| NCT03299452 ↗ | Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor | Unknown status | Alphacait, LLC | Phase 2 | 2017-01-01 | This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Desmopressin Acetate
Condition Name
Clinical Trial Locations for Desmopressin Acetate
Trials by Country
Clinical Trial Progress for Desmopressin Acetate
Clinical Trial Phase
Clinical Trial Sponsors for Desmopressin Acetate
Sponsor Name
